arXiv · 2112.13686
Radiomic biomarker extracted from PI-RADS 3 patients support more e\`icient and robust prostate cancer diagnosis: a multi-center study
Abstract
Prostate Imaging Reporting and Data System (PI-RADS) based on multi-parametric MRI classi\^ees patients into 5 categories (PI-RADS 1-5) for routine clinical diagnosis guidance. However, there is no consensus on whether PI-RADS 3 patients should go through biopsies. Mining features from these hard samples (HS) is meaningful for physicians to achieve accurate diagnoses. Currently, the mining of HS biomarkers is insu\`icient, and the e\'eectiveness and robustness of HS biomarkers for prostate cancer diagnosis have not been explored. In this study, biomarkers from di\'eerent data distributions are constructed. Results show that HS biomarkers can achieve better performances in di\'eerent data distributions.
Explore related subjects
Keep this discovery
Longfei Li, Rui Yang, Xin Chen, Cheng Li, Hairong Zheng, Yusong Lin, Zaiyi Liu, Shanshan Wang. 2021-12-23. Radiomic biomarker extracted from PI-RADS 3 patients support more e\`icient and robust prostate cancer diagnosis: a multi-center study. https://arxiv.org/abs/2112.13686
Cite the original work for its findings. Save a collection to share your selection of sources.